Viewing nowCombinationJadigleemmet Tablet 12.5/1000 mg (Empagliflozin 2L-Proline, Metformin)
Empagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 202502869 · Approved 2025.11.05
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes. In particular, it effectively lowers blood glucose through the combination of empagliflozin and metformin. It can also be used in patients with type 2 diabetes who have cardiovascular disease and have difficulty with blood glucose control, but caution is required regarding cardiovascular events, so professional guidance should be followed. This drug safely and effectively helps improve blood glucose management and cardiovascular health.
The recommended dose of this medicine is 1 tablet twice daily. The dose is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily dose of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients in Whom the Medicine Must Not Be Used, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.
This drug is used for the treatment of diabetes and helps with blood glucose control. When taking this drug, rare side effects such as severe lactic acidosis may occur, so caution is advised. Lactic acidosis is a condition in which lactic acid accumulates excessively in the body and can be life-threatening. Additionally, when taken with other diabetes medications, hypoglycemia may occur, hence careful monitoring of blood glucose levels is essential. Patients with impaired kidney function or acute renal injury may be at risk when taking this medication, so it is imperative to follow a physician's instructions. In cases of severe infection, dehydration, or reduced cardiac function, this medication should be discontinued or used cautiously. Before and after tests using iodine contrast agents, this medication should be temporarily discontinued and can be resumed once kidney function returns to normal. It is safest for women who are pregnant or may become pregnant, as well as nursing mothers, to avoid taking this medication. This drug can cause fluid loss, so special attention should be given to elderly patients or those with low blood pressure to prevent dehydration and ensure adequate fluid intake. As vitamin B12 levels may decrease, regular blood testing may be necessary for long-term use. Symptoms of genital infections or urinary tract infections may arise during use, and immediate notification to healthcare personnel is required if symptoms occur. Hypoglycemic symptoms may be present, so it is important to monitor for dizziness, cold sweat, tremors, and to consume sugar immediately if necessary. If surgery is planned, this medication should be stopped 48 hours prior to the surgery, and can be resumed after confirming normal kidney function post-surgery. This medication should be administered to the elderly with frequent monitoring of kidney function, and starting at the lowest dose is recommended. In cases of overdose, serious side effects such as lactic acidosis or hypoglycemia may occur, necessitating immediate medical attention. Finally, this medication should be kept out of the reach of children and stored in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, hence it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature to preserve the medication's effectiveness for an extended period.
Brownish-purple, double-sided convex oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.56mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.